Evidence map›Paper›PMID 24555174›Full record

ArticleSpringerPlus2014

Donor-derived 47, XXY in an unrelated cord blood transplant recipient.

Kuniki Kawaguchi, Takayuki Nakamura, Masayuki Nohara, Satoko Koteda, Kei Nomura, Satoshi Morishige, Eijiro Oku, Rie Imamura, Fumihiko Mouri, Ritsuko Seki and 5 more

Open access · diamondAbstract read
In one paragraph

Article in SpringerPlus, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Kuniki KawaguchiDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Takayuki NakamuraDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Masayuki NoharaDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Satoko KotedaDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Kei NomuraDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Satoshi MorishigeDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Eijiro OkuDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Rie ImamuraDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Fumihiko MouriDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Ritsuko SekiDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Koichi OsakiDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Michitoshi HashiguchiDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Kohji YoshimotoDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Koji NagafujiDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Takashi OkamuraDepartment of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan.
Kurume University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 65-year-old Japanese male with therapy-related myelodysplastic syndrome was admitted for unrelated cord blood transplantation. A cord blood unit from a male donor was obtained from the Japan Cord Blood Bank Network. The patient then received a conditioning regimen consisting of fludarabine, intravenous busulfan, and total body irradiation. Successful engraftment was obtained. The bone marrow examination on day 28 revealed trilineage engraftment, and chimerism analysis by variable number of tandem repeat polymerase chain reaction confirmed complete donor chimerism. At that time, conventional cytogenetics of the bone marrow aspirate showed 20 out of 20 metaphases with the 47, XXY karyotype characteristic of Klinefelter syndrome. Klinefelter syndrome is the most common genetic cause of human male infertility with a reported prevalence of 0.1-0.2% in the general population. In Japan Cord Blood Bank Network, there is no informed consent from parents about the possibility that post-unrelated cord blood transplantation patient evaluation may reveal donor-origin inherited diseases including cytogenetic abnormality. It is desirable to have opportunities in Japan discussing whether parents will be notified of the possibility that post-unrelated cord blood transplantation evaluation may reveal donor-derived illness incidentally.

Indexed as

Chromosomal abnormalitiesCord bloodDonor-derivedHematopoietic stem cellTransplantation

Identifiers

PMID24555174
PMCPMC3923919
OpenAlexW2108270309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.